Continuous Manufacturing of Recombinant Drugs: Comprehensive Analysis of Cost Reduction Strategies, Regulatory Pathways, and Global Implementation

Gorde:

Xehetasun bibliografikoak
Argitaratua izan da:	Pharmaceuticals vol. 18, no. 8 (2025), p. 1157-1189
Egile nagusia:	Niazi, Sarfaraz K
Argitaratua:	MDPI AG
Gaiak:	Food & Drug Administration > FDA United States > US Germany Monoclonal antibodies Product quality Collaboration Real time Batch processes Process controls Biological products Pharmaceutical industry Capital expenditures Batch processing Manufacturing Cost control 19th century Product testing
Sarrera elektronikoa:	Citation/Abstract Full Text + Graphics Full Text - PDF
Etiketak:	Etiketa erantsi Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Izan zaitez lehena ohar bat uzten!